Arcutis Director Sells $121,000 Amid ZORYVE Revenue Surge
A biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Designed for total beginners, this overview covers the basics of Zero Based Budgeting, with simple actions to start budgeting effectively.
19,028 articlesA biotech insider sale of about $121,000 sits beside a strong ZORYVE revenue story. This article breaks down what it ...
Bitcoin’s rally back above $60,000 reversed sharply after June 25 inflation data, triggering a wave of long liquidati...
Looking for legitimate ways to monetize a few spare minutes? Apps for online surveys that pay let you turn quick poll...
May 2026 delivered a dramatic uptick in tokenized pre-IPO trading, led by SpaceX as the Nasdaq listing approached, wi...
Vanguard’s International High Dividend Yield ETF has raised payouts in 2025 and 2026, but the durability of its forei...
Gold continues its 2026 rally as inflation stays stubborn. Three bullion ETFs offer differing cost paths to own alloc...
Solana and XRP are locked in a tight race for crypto rankings, with market momentum and network utility shaping the p...
When a CEO buys thousands of shares, investors take note. This article breaks down the 74,000-share purchase by Energ...
U.S. households are trimming credit-card balances as total debt hovers near $1.25 trillion, signaling a shift in cons...
Point closes $508.6m securitization, the largest HEI-backed deal to date, as institutional buyers pile into home equi...
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
A flood of political spending from crypto firms aimed at shaping new laws has investors eyeing policy risk. This guid...